Literature DB >> 33139243

Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy.

Sarah-Maria Fendt1,2, Christian Frezza3, Ayelet Erez4.   

Abstract

Cancer cells continuously rewire their metabolism to fulfill their need for rapid growth and survival while subject to changes in environmental cues. Thus, a vital component of a cancer cell lies in its metabolic adaptability. The constant demand for metabolic alterations requires flexibility, that is, the ability to utilize different metabolic substrates; as well as plasticity, that is, the ability to process metabolic substrates in different ways. In this review, we discuss how dynamic changes in cancer metabolism affect tumor progression and the consequential implications for cancer therapy. SIGNIFICANCE: Recognizing cancer dynamic metabolic adaptability as an entity can lead to targeted therapy that is expected to decrease drug resistance. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2020        PMID: 33139243      PMCID: PMC7710573          DOI: 10.1158/2159-8290.CD-20-0844

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   38.272


  102 in total

1.  Reactivation of Dihydroorotate Dehydrogenase-Driven Pyrimidine Biosynthesis Restores Tumor Growth of Respiration-Deficient Cancer Cells.

Authors:  Martina Bajzikova; Jaromira Kovarova; Ana R Coelho; Stepana Boukalova; Sehyun Oh; Katerina Rohlenova; David Svec; Sona Hubackova; Berwini Endaya; Kristyna Judasova; Ayenachew Bezawork-Geleta; Katarina Kluckova; Laurent Chatre; Renata Zobalova; Anna Novakova; Katerina Vanova; Zuzana Ezrova; Ghassan J Maghzal; Silvia Magalhaes Novais; Marie Olsinova; Linda Krobova; Yong Jin An; Eliska Davidova; Zuzana Nahacka; Margarita Sobol; Teresa Cunha-Oliveira; Cristian Sandoval-Acuña; Hynek Strnad; Tongchuan Zhang; Thanh Huynh; Teresa L Serafim; Pavel Hozak; Vilma A Sardao; Werner J H Koopman; Miria Ricchetti; Paulo J Oliveira; Frantisek Kolar; Mikael Kubista; Jaroslav Truksa; Katerina Dvorakova-Hortova; Karel Pacak; Robert Gurlich; Roland Stocker; Yaoqi Zhou; Michael V Berridge; Sunghyouk Park; Lanfeng Dong; Jakub Rohlena; Jiri Neuzil
Journal:  Cell Metab       Date:  2018-11-15       Impact factor: 27.287

2.  Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1.

Authors:  Stéphanie Herkenne; Olivier Ek; Margherita Zamberlan; Anna Pellattiero; Maya Chergova; Iñigo Chivite; Eliška Novotná; Giovanni Rigoni; Tiago Branco Fonseca; Dijana Samardzic; Andrielly Agnellini; Camilla Bean; Giulietta Di Benedetto; Natascia Tiso; Francesco Argenton; Antonella Viola; Maria Eugenia Soriano; Marta Giacomello; Elena Ziviani; Gabriele Sales; Marc Claret; Mariona Graupera; Luca Scorrano
Journal:  Cell Metab       Date:  2020-04-20       Impact factor: 27.287

3.  Extracellular metabolic energetics can promote cancer progression.

Authors:  Jia Min Loo; Alexis Scherl; Alexander Nguyen; Fung Ying Man; Ethan Weinberg; Zhaoshi Zeng; Leonard Saltz; Philip B Paty; Sohail F Tavazoie
Journal:  Cell       Date:  2015-01-15       Impact factor: 41.582

Review 4.  Metabolic dysregulation in monogenic disorders and cancer - finding method in madness.

Authors:  Ayelet Erez; Ralph J DeBerardinis
Journal:  Nat Rev Cancer       Date:  2015-06-18       Impact factor: 69.800

5.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

Review 6.  Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality.

Authors:  Alan McIntyre; Adrian L Harris
Journal:  EMBO Mol Med       Date:  2015-04       Impact factor: 12.137

7.  Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells.

Authors:  Ilaria Elia; Dorien Broekaert; Stefan Christen; Ruben Boon; Enrico Radaelli; Martin F Orth; Catherine Verfaillie; Thomas G P Grünewald; Sarah-Maria Fendt
Journal:  Nat Commun       Date:  2017-05-11       Impact factor: 14.919

Review 8.  The Chaperone TRAP1 As a Modulator of the Mitochondrial Adaptations in Cancer Cells.

Authors:  Ionica Masgras; Carlos Sanchez-Martin; Giorgio Colombo; Andrea Rasola
Journal:  Front Oncol       Date:  2017-03-29       Impact factor: 6.244

9.  Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation.

Authors:  Yan Long; Wen-Bin Tsai; Jeffrey T Chang; Marcos Estecio; Medhi Wangpaichitr; Naramol Savaraj; Lynn G Feun; Helen H W Chen; Macus Tien Kuo
Journal:  Oncotarget       Date:  2016-12-13

10.  Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion.

Authors:  Cristovão M Sousa; Douglas E Biancur; Xiaoxu Wang; Christopher J Halbrook; Mara H Sherman; Li Zhang; Daniel Kremer; Rosa F Hwang; Agnes K Witkiewicz; Haoqiang Ying; John M Asara; Ronald M Evans; Lewis C Cantley; Costas A Lyssiotis; Alec C Kimmelman
Journal:  Nature       Date:  2016-08-10       Impact factor: 49.962

View more
  33 in total

Review 1.  Tumour fatty acid metabolism in the context of therapy resistance and obesity.

Authors:  Andrew J Hoy; Shilpa R Nagarajan; Lisa M Butler
Journal:  Nat Rev Cancer       Date:  2021-08-20       Impact factor: 60.716

2.  Multi-omics characterization of the unsaturated fatty acid biosynthesis pathway in colon cancer.

Authors:  Ling Chen; Chang-Shun Yang; Si-Dong Chen; Qiao-Xia Zhou; Guo-Qiang Wang; Shang-Li Cai; Wei-Hua Li; Hong-Zhi Luo
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

Review 3.  Nonsense-mediated RNA decay: an emerging modulator of malignancy.

Authors:  Kun Tan; Dwayne G Stupack; Miles F Wilkinson
Journal:  Nat Rev Cancer       Date:  2022-05-27       Impact factor: 69.800

Review 4.  Extracellular vesicles and particles impact the systemic landscape of cancer.

Authors:  Serena Lucotti; Candia M Kenific; Haiying Zhang; David Lyden
Journal:  EMBO J       Date:  2022-09-02       Impact factor: 14.012

Review 5.  Deciphering Metabolic Adaptability of Leukemic Stem Cells.

Authors:  Sweta B Patel; Travis Nemkov; Angelo D'Alessandro; Robert S Welner
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

6.  An overview of "Chronic viral infection and cancer, openings for vaccines" virtual symposium of the TechVac Network - December 16-17, 2021.

Authors:  Maria G Isaguliants; Ivan Trotsenko; Franco M Buonaguro
Journal:  Infect Agent Cancer       Date:  2022-07-08       Impact factor: 3.698

Review 7.  Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer.

Authors:  Marilyne Labrie; Joan S Brugge; Gordon B Mills; Ioannis K Zervantonakis
Journal:  Nat Rev Cancer       Date:  2022-03-09       Impact factor: 69.800

Review 8.  Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy.

Authors:  Isabella Giacomini; Federico Gianfanti; Maria Andrea Desbats; Genny Orso; Massimiliano Berretta; Tommaso Prayer-Galetti; Eugenio Ragazzi; Veronica Cocetta
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

9.  Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA.

Authors:  Alexander N Gorelick; Minsoo Kim; Walid K Chatila; Konnor La; A Ari Hakimi; Michael F Berger; Barry S Taylor; Payam A Gammage; Ed Reznik
Journal:  Nat Metab       Date:  2021-04-08

Review 10.  Effect of glutamine metabolism on chemoresistance and its mechanism in tumors.

Authors:  Xinyang Hu; Hongchuan Jin; Liyuan Zhu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.